These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 9170469)

  • 61. The relationship between unexplained elevated serum markers in triple test, uterine artery Doppler measurements and adverse pregnancy outcome.
    Karsidag AY; Buyukbayrak EE; Kars B; Suyugul U; Unal O; Turan MC
    J Pak Med Assoc; 2010 Mar; 60(3):181-6. PubMed ID: 20225773
    [TBL] [Abstract][Full Text] [Related]  

  • 62. First-trimester screening for trisomy 21 by free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A: impact of maternal and pregnancy characteristics.
    Kagan KO; Wright D; Spencer K; Molina FS; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 May; 31(5):493-502. PubMed ID: 18432600
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Medians and correction factors for biochemical and ultrasound markers in Chinese women undergoing first-trimester screening for trisomy 21.
    Sahota DS; Leung TY; Fung TY; Chan LW; Law LW; Lau TK
    Ultrasound Obstet Gynecol; 2009 Apr; 33(4):387-93. PubMed ID: 19306471
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The effect of temporal variation in biochemical markers of trisomy 21 across the first and second trimesters of pregnancy on the estimation of individual patient-specific risks and detection rates for Down's syndrome.
    Spencer K; Crossley JA; Aitken DA; Nix AB; Dunstan FD; Williams K
    Ann Clin Biochem; 2003 May; 40(Pt 3):219-31. PubMed ID: 12803832
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Unexplained elevated midtrimester maternal serum levels of alpha fetoprotein, human chorionic gonadotropin, or low unconjugated estriol: recurrence risk and association with adverse perinatal outcome.
    Wax JR; Lopes AM; Benn PA; Lerer T; Steinfeld JD; Ingardia CJ
    J Matern Fetal Med; 2000; 9(3):161-4. PubMed ID: 10914623
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Co-variables in first trimester maternal serum screening.
    de Graaf IM; Cuckle HS; Pajkrt E; Leschot NJ; Bleker OP; van Lith JM
    Prenat Diagn; 2000 Mar; 20(3):186-9. PubMed ID: 10719318
    [TBL] [Abstract][Full Text] [Related]  

  • 67. First trimester predictors of adverse pregnancy outcomes.
    Brameld KJ; Dickinson JE; O'Leary P; Bower C; Goldblatt J; Hewitt B; Murch A; Stock R
    Aust N Z J Obstet Gynaecol; 2008 Dec; 48(6):529-35. PubMed ID: 19133038
    [TBL] [Abstract][Full Text] [Related]  

  • 68. hCG and the free beta-subunit as screening tests for Down syndrome.
    Knight GJ; Palomaki GE; Neveux LM; Fodor KK; Haddow JE
    Prenat Diagn; 1998 Mar; 18(3):235-45. PubMed ID: 9556040
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The association of triple-marker test results with adverse pregnancy outcomes in low-risk pregnancies with healthy newborns.
    Sayin NC; Canda MT; Ahmet N; Arda S; Süt N; Varol FG
    Arch Gynecol Obstet; 2008 Jan; 277(1):47-53. PubMed ID: 17653738
    [TBL] [Abstract][Full Text] [Related]  

  • 70. New cut-off values for screening of trisomy 21, 18 and open neural tube defects (ONTD) during the second trimester in pregnant women with advanced maternal age.
    Chen Y; Wang X; Li L; Lu S; Zhang Z
    BMC Pregnancy Childbirth; 2020 Dec; 20(1):776. PubMed ID: 33317474
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Screening by maternal serum markers for Down's syndrome].
    Liu JT; Hao N; Sun NH; Wang FY; Xu YH; Gai MY; Bian XM; Yang JQ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Apr; 25(2):156-9. PubMed ID: 12905710
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Biochemical screening for Down syndrome.
    Cuckle H
    Eur J Obstet Gynecol Reprod Biol; 2000 Sep; 92(1):97-101. PubMed ID: 10986441
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Maternal serum biochemistry at 11-13(+6) weeks in relation to the presence or absence of the fetal nasal bone on ultrasonography in chromosomally abnormal fetuses: an updated analysis of integrated ultrasound and biochemical screening.
    Cicero S; Spencer K; Avgidou K; Faiola S; Nicolaides KH
    Prenat Diagn; 2005 Nov; 25(11):977-83. PubMed ID: 16245371
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Correlation of ultrasound findings and biochemical markers in the second trimester of pregnancy in fetuses with trisomy 21.
    Souter VL; Nyberg DA; El-Bastawissi A; Zebelman A; Luthhardt F; Luthy DA
    Prenat Diagn; 2002 Mar; 22(3):175-82. PubMed ID: 11920888
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Maternal serum screening for Down's syndrome: the effect of routine ultrasound scan determination of gestational age and adjustment for maternal weight.
    Wald NJ; Cuckle HS; Densem JW; Kennard A; Smith D
    Br J Obstet Gynaecol; 1992 Feb; 99(2):144-9. PubMed ID: 1372820
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The impact of correcting for smoking status when screening for chromosomal anomalies using maternal serum biochemistry and fetal nuchal translucency thickness in the first trimester of pregnancy.
    Spencer K; Bindra R; Cacho AM; Nicolaides KH
    Prenat Diagn; 2004 Mar; 24(3):169-73. PubMed ID: 15057947
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Prospective prenatal serum screening for Down syndrome in Venezuela.
    Alvarez-Nava F; Soto M; Morales-Machín A; Rojas A; Urdaneta K; Cañizález J
    Int J Gynaecol Obstet; 2008 Dec; 103(3):241-5. PubMed ID: 18817910
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [The value of maternal first and second trimester serum data of β-hCG, PAPP-A, AFP and uE3 in the prediction of preeclampsia].
    Gu W; Lin J; Hou Y
    Zhonghua Fu Chan Ke Za Zhi; 2015 Feb; 50(2):101-7. PubMed ID: 25877605
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Association Analysis between Maternal Serum Biomarkers and Fetal Congenital Heart Disease.
    Jiang H; Lin Y; He X
    Heart Surg Forum; 2023 Oct; 26(5):E552-E559. PubMed ID: 37920073
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Prenatal screening for major fetal defects by using of maternal serum markers].
    Bao P; Wu Y; Gu Q
    Zhonghua Fu Chan Ke Za Zhi; 1997 Nov; 32(11):649-51. PubMed ID: 9639762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.